Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation

Abstract

Premature ejaculation (PE), the most common sexual dysfunctions in men, is characterized by loss or absence of ejaculatory control. PE can be classified as either a lifelong or acquired condition. Although the prevalence of lifelong PE is rather low in the general male population, recent studies demonstrated that the patients who seek treatment for their rapid ejaculation mostly report lifelong PE. Although no drug for PE has been approved by regulatory bodies, chronic selective serotonin reuptake inhibitors (SSRIs) proved to be effective in treating lifelong PE. Despite the rising use and known effects of antidepressants on ejaculation, only a few reports have evaluated the impact of these drugs on the male fertility. Thus, the aim of this review is to evaluate the efficacy and adverse effects of SSRIs on semen parameters of patients with lifelong PE as well as to assess the safety of this treatment among sexually active couples who desire to have a child.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. American Psychiatric Association. Diagnostic criteria from DSM-IV-TR. American Psychiatric Association: Washington, DC, 2000.

  2. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J . The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: prevalence, comorbidites, and professional help-seeking. Eur Urol 2007; 51: 816–824.

    Article  PubMed  Google Scholar 

  3. Read S, King M, Watson J . Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med 1997; 19: 387–391.

    Article  CAS  PubMed  Google Scholar 

  4. Giuliano F, Patrick DL, Porst H . Premature ejaculation: results from a five country European observational study. Eur Urol 2008; 53: 1048–1057.

    Article  PubMed  Google Scholar 

  5. Sotomayor M . The burden of premature ejaculation: the patient's perspective. J Sex Med 2005; 2: 110–114.

    Article  PubMed  Google Scholar 

  6. Symonds T, Roblin D, Hart K, Althof S . How does premature ejaculation impact a man's life? J Sex Mar Ther 2003; 29: 361–370.

    Article  CAS  Google Scholar 

  7. Godpodinoff ML . Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther 1989; 15: 130–134.

    Article  CAS  PubMed  Google Scholar 

  8. McMahon CG, Althof S, Waldinger MD, Porst H, Dean J, Sharlip I et al. An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine ad hoc committee for the definition of premature ejaculation. J Sex Med 2008; 5: 1590–1606.

    Article  PubMed  Google Scholar 

  9. Giuliano F, Clement P . Serotonin and premature ejaculation: from physiology to patient management. Eur Urol 2006; 50: 454–466.

    Article  CAS  PubMed  Google Scholar 

  10. Wespes E, Amar E, Eardly I, Giuliano F, Hatzichristou D, Hatzimouratidis K et al. Guidelines on Male Sexual Dysfunction: erectile dysfunction and premature ejaculation. European Association of Urology Guidelines, Drukkerij Gelderlandbv. Arnhem-Netherlands 2011; 31–46.

  11. Safarinejad MR . Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chromatin structure assay. J Urol 2008; 180: 2124–2128.

    Article  PubMed  Google Scholar 

  12. Tanrikut C, Feldman AS, Altemus M, Paduch DA, Schlegel PN . Adverse effect of paroxetine on sperm. Fertil Steril 2010; 94: 1021–1026.

    Article  CAS  PubMed  Google Scholar 

  13. Koyuncu HH, Serefoglu EC, Yencilek E, Atalay H, Akbas N, Sarica K . Escitalopram treatment for premature ejaculation has a negative effect on semen parameters. Int J Impot Res 2011; 23: 257–261.

    Article  CAS  PubMed  Google Scholar 

  14. Arafa M, Shamloul R . A randomized study examining the effect of 3 SSRI on premature ejaculation using a validated questionnaire. Ther Clin Risk Manag 2007; 3: 527–531.

    PubMed  PubMed Central  Google Scholar 

  15. Safarinejad RM . Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind placebo-controlled, fixed dose, randomized study. J Clin Psychopharmacol 2007; 27: 444–450.

    Article  CAS  PubMed  Google Scholar 

  16. Waldinger MD, Zwinderman AH, Schweitzer DH . Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 2004; 16: 369–381.

    Article  CAS  PubMed  Google Scholar 

  17. Waldinger MD, Van De Plas A, Pattij T, Van Oorschot R, Coolen LM, Veening JG et al. The selective serotonin re-uptake inhibitors fluvoxamine and paroxetine differ in sexual inhibitory effects after chronic treatment. Psychopharmacology 2002; 160: 283–289.

    Article  CAS  PubMed  Google Scholar 

  18. Waldinger MD, Berendsen HH, Blok BF, Olivier, Holstege G . Premature ejaculation and SSRI-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998; 92: 111–118.

    Article  CAS  PubMed  Google Scholar 

  19. Waldinger MD, Olivier B . Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacol 1998; 13: 27–33.

    Article  Google Scholar 

  20. Hellstrom WJG . Emerging treatments for premature ejaculation: focus on dapoxetine. Neuropsychiatr Dis Treat 2009; 5: 37–46.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Wylie KR, Ralph D . Premature ejaculation: the current literature. Curr Opin Urol 2005; 15: 393–398.

    Article  PubMed  Google Scholar 

  22. Sadeghi-Nejad H, Watson W . Premature ejaculation: current medical treatment and new directions. J Sex Med 2008; 5: 1037–1050.

    Article  CAS  PubMed  Google Scholar 

  23. Waldinger MD . Premature ejaculation: definition and drug treatment. Drugs 2007; 67: 547–568.

    Article  CAS  PubMed  Google Scholar 

  24. Montejo AL, Llorca G, Izquierdo JA, Rico-Willademoros F . Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psycholotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001; 62: 10–21.

    CAS  PubMed  Google Scholar 

  25. Wolf WA, Kuhn DM . Role of essential sulfhdryl groups in drug interactions at the neuronal 5-HT transporter. Differences between amphetamines and 5-HT uptake inhibitors. J Biol Chem 1992; 267: 20820–20825.

    CAS  PubMed  Google Scholar 

  26. De Lamirande E, Gagnon C . Paradoxical effect of reagents for sulfhydryl and disulfide groups on human sperm capacitation and superoxide production. Free Radic Biol Med 1998; 257: 803–817.

    Article  Google Scholar 

  27. De Lamirande E, Gagnon C . Redox control of changes in protein sulfhydryl levels during human sperm capacitation. Free Radic Biol Med 2003; 35: 1271–1285.

    Article  CAS  PubMed  Google Scholar 

  28. Kumar K, Sharma LV, Tiwari P, Singh D, Maikhuri JP, Gupta G et al. The spermicidal and antitrichomonas activities of SSRI antidepressants. Bioorg Med Chem Lett 2006; 16: 2509–2512.

    Article  CAS  PubMed  Google Scholar 

  29. Tanrikut C, Schegel PN . Antidepressant-associated changes in semen parameters. Urology 2007; 69: 185–187.

    Article  PubMed  Google Scholar 

  30. Evenson DP, Jost LK, Marshall D, Zinaman MJ, Clegg E, Purvis K . Utility of the sperm chromatin structure assay as diagnostic and prognostic tool in the human fertility clinic. Hum Reprod 1999; 14: 1039–1049.

    Article  CAS  PubMed  Google Scholar 

  31. Irvine DS, Twigg JP, Gordon EL, Fulton N, Milne PA, Aitken RJ . DNA integrity in human spermatozoa: relationships with semen quality. J Androl 2000; 21: 33–44.

    CAS  PubMed  Google Scholar 

  32. Spano M, Bonde JP, Hjollund HI, Kolstad HA, Cordelli E, Leter G . Sperm chromatin damage impairs human fertility. The Danish First Pregnancy Planner Study Team. Fertil Steril 2000; 73: 43–50.

    Article  CAS  PubMed  Google Scholar 

  33. Lopes S, Sun JG, Jurisicova A, Meriano J, Casper RF . Sperm deoxyribonucleic acid fragmentation is increased in poor-quality semen samples and correlates with failed fertilization in intracytoplasmic sperm injection. Fertil Steril 1998; 69: 528–532.

    Article  CAS  PubMed  Google Scholar 

  34. Tanaka E, Baba N, Toshida K, Suzuki K . Evidence for 5HT2 receptor involvement in the stimulation of preovulatory LH and prolactin release and ovulation in normal cycling rats. Life Sci 1993; 52: 669–676.

    Article  CAS  PubMed  Google Scholar 

  35. Meltzer H, Bastani B, Jayathilake K, Maes M . Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder. Neuropsychopharmacology 1997; 17: 1.

    Article  CAS  PubMed  Google Scholar 

  36. World Health Organization. WHO Manual for the Standardised Investigation and Diagnosis of the Infertile Couple. Cambridge: Cambridge University Press, 2000.

  37. Nieschlag E, Behre HM (eds) Andrology: Male Reproductive Health and Dysfunction, 2nd edn. Springer Verlag: Berlin, chapter 5, 2009 p 83–87.

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E C Serefoglu.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koyuncu, H., Serefoglu, E., Ozdemir, A. et al. Deleterious effects of selective serotonin reuptake inhibitor treatment on semen parameters in patients with lifelong premature ejaculation. Int J Impot Res 24, 171–173 (2012). https://doi.org/10.1038/ijir.2012.12

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijir.2012.12

Keywords

This article is cited by

Search

Quick links